● TIER 3 — Information onlyGRADE BGH secretagogues & GH axis
GHRP-2 / GHRP-6 / Hexarelin
GH-releasing peptides. Research verification: Yes (TGA pending). 1 human study record(s) in the FitClinicMD studies database.
GOALS · Muscle / body composition
FDA status
Not approved in US.
Compounding (503A/503B)
GHRP-2 (inj/nasal) and GHRP-6: 503B Category 2 (Sep 29 2023)
DEA
Not controlled.
WADA (sport)
S2.2.4 GH-releasing factors: GHRH & analogues (CJC-1295, sermorelin, tesamorelin), GHS (ibutamoren, ipamorelin), GHRPs (GHRP-2/6, hexarelin)
Mechanism
GHS-R1a agonists.
Human evidence · 1
Review of hexarelin cardiac/metabolic data. Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.
Reference only. This page summarizes publicly available regulatory and research information about GHRP-2 / GHRP-6 / Hexarelin. It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.